ATHERSYS, INC / NEW

2022 Q4 Form 10-Q Financial Statement

#000136814822000152 Filed on November 14, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3

Balance Sheet

Concept 2022 Q4 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $9.038M $13.78M
YoY Change -75.84% -72.25%
Cash & Equivalents $9.000M $13.80M
Short-Term Investments
Other Short-Term Assets $5.917M $6.306M
YoY Change 40.68% 205.23%
Inventory
Prepaid Expenses
Receivables $700.0K $660.0K
Other Receivables $0.00 $0.00
Total Short-Term Assets $13.54M $20.75M
YoY Change -70.59% -64.31%
LONG-TERM ASSETS
Property, Plant & Equipment $4.214M $5.438M
YoY Change 14.14% 50.51%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.136M $1.226M
YoY Change 136.02% -18.86%
Total Long-Term Assets $14.20M $14.80M
YoY Change 0.28% 6.04%
TOTAL ASSETS
Total Short-Term Assets $13.54M $20.75M
Total Long-Term Assets $14.20M $14.80M
Total Assets $27.73M $35.54M
YoY Change -53.92% -50.7%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $27.77M $29.18M
YoY Change 64.29% 70.85%
Accrued Expenses $1.078M $1.108M
YoY Change 53.13% 92.03%
Deferred Revenue $0.00
YoY Change -100.0%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $38.44M $38.73M
YoY Change 28.74% 39.92%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $5.199M $119.0K
YoY Change -99.21%
Total Long-Term Liabilities $5.199M $119.0K
YoY Change -99.21%
TOTAL LIABILITIES
Total Short-Term Liabilities $38.44M $38.73M
Total Long-Term Liabilities $5.199M $119.0K
Total Liabilities $51.58M $38.85M
YoY Change 72.74% -9.11%
SHAREHOLDERS EQUITY
Retained Earnings -$655.9M -$642.9M
YoY Change 12.43% 14.47%
Common Stock $632.0M $626.3M
YoY Change 5.39% 5.97%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$23.85M -$16.61M
YoY Change
Total Liabilities & Shareholders Equity $27.73M $35.54M
YoY Change -53.92% -50.7%

Cashflow Statement

Concept 2022 Q4 2022 Q3

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Registrant Name
EntityRegistrantName
ATHERSYS, INC / NEW
dei Entity Central Index Key
EntityCentralIndexKey
0001368148
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.04
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-33876
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-4864095
dei Entity Address Address Line1
EntityAddressAddressLine1
3201 Carnegie Avenue,
dei Entity Address City Or Town
EntityAddressCityOrTown
Cleveland,
dei Entity Address State Or Province
EntityAddressStateOrProvince
OH
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
44115-2634
dei City Area Code
CityAreaCode
216
dei Local Phone Number
LocalPhoneNumber
431-9900
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
ATHX
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
12933736 shares
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13782000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
37407000 usd
CY2022Q3 athx Prepaid Clinical Trial Costs
PrepaidClinicalTrialCosts
4889000 usd
CY2021Q4 athx Prepaid Clinical Trial Costs
PrepaidClinicalTrialCosts
2861000 usd
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1417000 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1345000 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
20748000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
46027000 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8131000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8960000 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5438000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3692000 usd
CY2022Q3 athx Deposits And Other Assets Non Current
DepositsAndOtherAssetsNonCurrent
1226000 usd
CY2021Q4 athx Deposits And Other Assets Non Current
DepositsAndOtherAssetsNonCurrent
1505000 usd
CY2022Q3 us-gaap Assets
Assets
35543000 usd
CY2021Q4 us-gaap Assets
Assets
60184000 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
845000 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1011000 usd
CY2022Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1553000 usd
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4133000 usd
CY2022Q3 athx Accrued Clinical Trial Costs Current
AccruedClinicalTrialCostsCurrent
4094000 usd
CY2021Q4 athx Accrued Clinical Trial Costs Current
AccruedClinicalTrialCostsCurrent
3773000 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1108000 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
704000 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
38729000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
29861000 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8109000 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8755000 usd
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
119000 usd
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
0 usd
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000 shares
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12933736 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12933736 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9713767 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9713767 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
13000 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
10000 usd
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
626251000 usd
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
599703000 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-642877000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-583344000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-16613000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
16369000 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
35543000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
60184000 usd
CY2022Q3 us-gaap Revenues
Revenues
65000 usd
CY2021Q3 us-gaap Revenues
Revenues
4792000 usd
us-gaap Revenues
Revenues
5294000 usd
us-gaap Revenues
Revenues
4792000 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12424000 usd
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
17162000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
54162000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
52361000 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3737000 usd
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3632000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12999000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16627000 usd
CY2022Q3 us-gaap Depreciation
Depreciation
617000 usd
CY2021Q3 us-gaap Depreciation
Depreciation
220000 usd
us-gaap Depreciation
Depreciation
1482000 usd
us-gaap Depreciation
Depreciation
1187000 usd
CY2022Q3 us-gaap Costs And Expenses
CostsAndExpenses
16778000 usd
CY2021Q3 us-gaap Costs And Expenses
CostsAndExpenses
21014000 usd
us-gaap Costs And Expenses
CostsAndExpenses
68643000 usd
us-gaap Costs And Expenses
CostsAndExpenses
70175000 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3044000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-16713000 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-16222000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-63349000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-65383000 usd
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
45000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3816000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
139000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-13669000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13669000 usd
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-16177000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-16177000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-59533000 usd
us-gaap Net Income Loss
NetIncomeLoss
-59533000 usd
us-gaap Net Income Loss
NetIncomeLoss
-65244000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-65244000 usd
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.15
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.15
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.76
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.76
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-5.58
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-5.58
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-7.41
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-7.41
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11855000 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11855000 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9169000 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9169000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10676000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10676000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8801000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8801000 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
16369000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1410000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-58000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-22216000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
307000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1945000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-40000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-23648000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-11738000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2001000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-33000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13669000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-16613000 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
31362000 usd
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3903000 usd
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-611000 usd
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-26468000 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
38681000 usd
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1788000 usd
CY2021Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-116000 usd
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-22599000 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
31046000 usd
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1407000 usd
CY2021Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-86000 usd
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-16177000 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
29347000 usd
us-gaap Net Income Loss
NetIncomeLoss
-59533000 usd
us-gaap Net Income Loss
NetIncomeLoss
-65244000 usd
us-gaap Depreciation
Depreciation
1482000 usd
us-gaap Depreciation
Depreciation
1187000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
5435000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
11000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
5356000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
7098000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
0 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
232000 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-2784000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 usd
athx Issuance Costs Allocated To Warrant Liabilities
IssuanceCostsAllocatedToWarrantLiabilities
560000 usd
athx Issuance Costs Allocated To Warrant Liabilities
IssuanceCostsAllocatedToWarrantLiabilities
usd
us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
-3754000 usd
us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
6311000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1262000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-699000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
4472000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
4047000 usd
athx Increase Decrease In Accounts Payable Related To Collaborative Arrangements
IncreaseDecreaseInAccountsPayableRelatedToCollaborativeArrangements
-1119000 usd
athx Increase Decrease In Accounts Payable Related To Collaborative Arrangements
IncreaseDecreaseInAccountsPayableRelatedToCollaborativeArrangements
-586000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-3340000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
2029000 usd
athx Increase Decrease In Contract With Customer Liability Advances From Customer
IncreaseDecreaseInContractWithCustomerLiabilityAdvancesFromCustomer
0 usd
athx Increase Decrease In Contract With Customer Liability Advances From Customer
IncreaseDecreaseInContractWithCustomerLiabilityAdvancesFromCustomer
-2000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-46990000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-56851000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
41000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 usd
us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
2044000 usd
us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
1154000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2003000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1154000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
14500000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
56944000 usd
us-gaap Proceeds From Other Equity
ProceedsFromOtherEquity
10997000 usd
us-gaap Proceeds From Other Equity
ProceedsFromOtherEquity
0 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
2000 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
131000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
814000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
25368000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
56130000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-23625000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1875000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
37407000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
51546000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13782000 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
49671000 usd
athx Issuance Of Warrants Noncash Activies
IssuanceOfWarrantsNoncashActivies
413000 usd
athx Issuance Of Warrants Noncash Activies
IssuanceOfWarrantsNoncashActivies
0 usd
athx Reclass Of Warrant Liability Upon Exercise Noncash Activity
ReclassOfWarrantLiabilityUponExerciseNoncashActivity
2231000 usd
athx Reclass Of Warrant Liability Upon Exercise Noncash Activity
ReclassOfWarrantLiabilityUponExerciseNoncashActivity
0 usd
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
us-gaap Use Of Estimates
UseOfEstimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Our critical accounting policies, estimates and assumptions are described in “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” which is included in this Quarterly Report on Form 10-Q.
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13800000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3692000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
5400000 usd
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5313231000 shares
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1407597000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5713231000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1407597000 shares
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
15894000 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
13810000 usd
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
10456000 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
10118000 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5438000 usd
CY2022Q3 us-gaap Restructuring Reserve Accelerated Depreciation
RestructuringReserveAcceleratedDepreciation
500000 usd
us-gaap Restructuring Reserve Accelerated Depreciation
RestructuringReserveAcceleratedDepreciation
900000 usd
CY2021Q3 us-gaap Restructuring Reserve Accelerated Depreciation
RestructuringReserveAcceleratedDepreciation
500000 usd
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
128168 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
893551 shares
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2000000 usd
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1400000 usd
CY2022Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
5600000 usd
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Payments For Restructuring
PaymentsForRestructuring
986000 usd
CY2022Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-2800000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-2800000 usd
CY2022Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
1900000 usd
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000 shares
CY2022Q2 athx Restructuring And Related Cost Reduction In Workforce Percentage
RestructuringAndRelatedCostReductionInWorkforcePercentage
0.70
CY2021Q4 us-gaap Restructuring Reserve
RestructuringReserve
0 usd
us-gaap Restructuring Charges
RestructuringCharges
2750000 usd
us-gaap Payments For Restructuring
PaymentsForRestructuring
1276000 usd
CY2022Q3 us-gaap Restructuring Reserve
RestructuringReserve
1474000 usd
CY2022Q2 us-gaap Restructuring Reserve
RestructuringReserve
2425000 usd
CY2022Q3 us-gaap Restructuring Charges
RestructuringCharges
35000 usd
CY2022Q3 us-gaap Restructuring Reserve
RestructuringReserve
1474000 usd

Files In Submission

Name View Source Status
0001368148-22-000152-index-headers.html Edgar Link pending
0001368148-22-000152-index.html Edgar Link pending
0001368148-22-000152.txt Edgar Link pending
0001368148-22-000152-xbrl.zip Edgar Link pending
athx-20220930.htm Edgar Link pending
athx-20220930.xsd Edgar Link pending
ex31120220930.htm Edgar Link pending
ex31220220030.htm Edgar Link pending
ex32120220930.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
athx-20220930_def.xml Edgar Link unprocessable
athx-20220930_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
athx-20220930_htm.xml Edgar Link completed
report.css Edgar Link pending
Show.js Edgar Link pending
athx-20220930_cal.xml Edgar Link unprocessable
athx-20220930_pre.xml Edgar Link unprocessable